Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
Huseyin Naci(London School of Economics and Political Science), Christopher M. Booth(Queen's University), Xochitl Romo-Sandoval(London School of Economics and Political Science), Julian P. T. Higgins(Kleijnen Systematic Reviews (United Kingdom)), Bishal Gyawali(Nagoya University Hospital), Courtney Davis(King's College London), Jonathan A C Sterne, Nicola Handley(King's College London), Jelena Savović(University of Bristol)
Cited by 242
Related Papers
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
|JAMA|2003|1.4k
Consistency and inconsistency in network meta‐analysis: model estimation using multivariate meta‐regression
|Research Synthesis Methods|2012|1.1k
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
|The Lancet HIV|2017|1.1k
Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews
|International Journal of Epidemiology|2012|845